ES2715400T3 - Uso de microorganismos para la prevención y el tratamiento de enfermedades intestinales - Google Patents

Uso de microorganismos para la prevención y el tratamiento de enfermedades intestinales Download PDF

Info

Publication number
ES2715400T3
ES2715400T3 ES14702838T ES14702838T ES2715400T3 ES 2715400 T3 ES2715400 T3 ES 2715400T3 ES 14702838 T ES14702838 T ES 14702838T ES 14702838 T ES14702838 T ES 14702838T ES 2715400 T3 ES2715400 T3 ES 2715400T3
Authority
ES
Spain
Prior art keywords
dsm
acetylcholine
intestinal
producing microorganism
microorganism
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES14702838T
Other languages
English (en)
Spanish (es)
Inventor
Jürgen Mayer
Dirk Haller
Anna Zhenchuk
Thomas Hofmann
Andreas Dunkel
Michael Schemann
Dagmar Krüger
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LUDWIG STOCKER HOFPFISTEREI GmbH
Original Assignee
LUDWIG STOCKER HOFPFISTEREI GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LUDWIG STOCKER HOFPFISTEREI GmbH filed Critical LUDWIG STOCKER HOFPFISTEREI GmbH
Application granted granted Critical
Publication of ES2715400T3 publication Critical patent/ES2715400T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/177—Receptors; Cell surface antigens; Cell surface determinants
    • A61K38/1787—Receptors; Cell surface antigens; Cell surface determinants for neuromediators, e.g. serotonin receptor, dopamine receptor
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/26—Processes using, or culture media containing, hydrocarbons
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P13/00—Preparation of nitrogen-containing organic compounds
    • C12P13/001—Amines; Imines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K2035/11—Medicinal preparations comprising living procariotic cells
    • A61K2035/115—Probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225—Lactobacillus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225—Lactobacillus
    • C12R2001/24—Lactobacillus brevis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225—Lactobacillus
    • C12R2001/25—Lactobacillus plantarum

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Wood Science & Technology (AREA)
  • Mycology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Nutrition Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Cell Biology (AREA)
  • Neurology (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ES14702838T 2013-02-05 2014-02-04 Uso de microorganismos para la prevención y el tratamiento de enfermedades intestinales Active ES2715400T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP13153996 2013-02-05
PCT/EP2014/052129 WO2014122119A1 (en) 2013-02-05 2014-02-04 Use of microorganisms for the prevention and treatment of intestinal diseases

Publications (1)

Publication Number Publication Date
ES2715400T3 true ES2715400T3 (es) 2019-06-04

Family

ID=47630212

Family Applications (1)

Application Number Title Priority Date Filing Date
ES14702838T Active ES2715400T3 (es) 2013-02-05 2014-02-04 Uso de microorganismos para la prevención y el tratamiento de enfermedades intestinales

Country Status (5)

Country Link
US (2) US20150374763A1 (enExample)
EP (1) EP2953484B1 (enExample)
JP (1) JP6486837B2 (enExample)
ES (1) ES2715400T3 (enExample)
WO (1) WO2014122119A1 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101909083B1 (ko) * 2016-08-02 2018-10-17 한국과학기술연구원 실리마린을 포함하는 장 건강 개선용 조성물
RU2675110C1 (ru) * 2018-04-09 2018-12-17 Федеральное государственное бюджетное учреждение науки Институт общей генетики им. Н.И. Вавилова Российской академии наук (ИОГЕН РАН) Фармацевтическая композиция для терапии воспалительных заболеваний слизистых оболочек кишечника на основе штамма Lactobacillus brevis 47f, проявляющая местную противовоспалительную активность
CN109337836B (zh) * 2018-10-26 2021-11-26 贵州茅台酒股份有限公司 一种乳酸菌分离培养基及其制备方法及乳酸菌筛选方法
CN112870188A (zh) * 2019-11-29 2021-06-01 复旦大学附属华山医院 一种缓解炎症的乙酰胆碱免疫调节剂及其制备方法和应用
JPWO2023068279A1 (enExample) * 2021-10-18 2023-04-27

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4970207A (en) 1988-07-07 1990-11-13 Fujisawa Pharmaceutical Company, Ltd. Benzodiazepine derivatives
US5443826A (en) 1988-08-02 1995-08-22 Borody; Thomas J. Treatment of gastro-intestinal disorders with a fecal composition or a composition of bacteroides and E. Coli
US5547961A (en) 1990-05-25 1996-08-20 Yamanouchi Pharmaceutical Co., Ltd. Method of treatment of intestinal diseases
JPH05507942A (ja) 1991-03-07 1993-11-11 ジー．ディー．サール　アンド　カンパニー 新規セロトニン作動性剤としての新規なｍｅｓｏ―アザ環式芳香族酸アミド化合物およびエステル化合物
GB9107305D0 (en) 1991-04-08 1991-05-22 Unilever Plc Probiotic
WO1995032963A1 (en) 1994-06-01 1995-12-07 Yoshitomi Pharmaceutical Industries, Ltd. Thienylazole compound and thienotriazolodiazepine compound
ITRM20060369A1 (it) 2006-07-17 2008-01-18 Giuliani Spa Miscela di batteri lattici per la preparazione di prodotti da forno senza glutine
WO2014072408A1 (en) * 2012-11-08 2014-05-15 Ludwig Stocker Hofpfisterei Gmbh Lactobacillus sanfranciscensis microorganisms from sourdough

Also Published As

Publication number Publication date
US20150374763A1 (en) 2015-12-31
JP2016508368A (ja) 2016-03-22
JP6486837B2 (ja) 2019-03-20
EP2953484A1 (en) 2015-12-16
EP2953484B1 (en) 2019-01-16
US20170333525A1 (en) 2017-11-23
US10912818B2 (en) 2021-02-09
WO2014122119A1 (en) 2014-08-14

Similar Documents

Publication Publication Date Title
US9504720B2 (en) Substance for preventing and improving arthritis
Verna et al. Use of probiotics in gastrointestinal disorders: what to recommend?
EP2857027B1 (en) Probiotic strains for use in improving the enteric nervous system
Spiller Probiotics and prebiotics in irritable bowel syndrome
CA2745341C (en) Means and methods for activating vagus nerve
ES2715400T3 (es) Uso de microorganismos para la prevención y el tratamiento de enfermedades intestinales
ES2389547B1 (es) Bifidobacterium cect 7765 y su uso en la prevención y/o tratamiento del sobrepeso, la obesidad y patologías asociadas.
CN108603162A (zh) 预防、改善或治疗退行性脑病或认知功能障碍的新型乳酸菌和组合物
Di Stefano et al. The effect of oral α-galactosidase on intestinal gas production and gas-related symptoms
ES2694567T3 (es) Producción y uso de histamina bacteriana
KR102254310B1 (ko) 락토바실러스 애시도필러스 kbl409 균주 및 그 용도
CA3223136A1 (en) Physiologically acceptable yeast compositions and uses thereof
Lou et al. Gut microbiota: a modulator and therapeutic target for chronic pain
Shimoyama et al. Study of the mechanisms of a J apanese traditional fermented medicine in the improvement of constipation
Borowiec et al. The role of probiotics in management of irritable bowel syndrome
US20240408155A1 (en) Probiotics complex composition with immunomodulatory and immune homeostasis property
Santos et al. Irritable bowel syndrome: the problem and the problem of treating it–is there a role for probiotics?
Andresen et al. Role of probiotics in the treatment of irritable bowel syndrome: potential mechanisms and current clinical evidence
Sako et al. The world’s oldest probiotic: perspectives for health claims
WO2020109646A1 (es) Phascolarctobacterium faecium para su uso en la prevención y tratamiento de la obesidad y sus comorbilidades
Singh et al. Therapeutic Potential of Synbiotics in Management of Various Disorders
RU2798872C2 (ru) ШТАММ Lactobacillus gasseri KBL697 И ЕГО ПРИМЕНЕНИЕ
Sydorchuk et al. Possibility of acute intestinal food-borne infections holiatry: approach with combined preand probiotic
Lembo et al. Complementary and alternative medicine and CBT in gastroenterology
KR101275227B1 (ko) 중증근무력증 예방, 개선 또는 치료용 조성물